Predicting immunotherapy response in lung cancer with AI and radiology
Part of Cancer, Lungs & breathing clinical trials.
This study uses artificial intelligence and CT scan analysis to predict how well lung cancer patients will respond to immunotherapy. It may help doctors choose the best treatment for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are being treated for lung cancer at Wuhan Union Hospital between July 2025 and July 2026.
- You are over 18 years old.
- You have had at least one CT scan before starting treatment.
- Your lung cancer diagnosis has been confirmed by a tissue biopsy.
- Your CT scans are clear enough for analysis, and your medical records are complete.
- You do not have another type of cancer besides lung cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses artificial intelligence (AI) to analyze your CT or MRI scans and help predict how well immunotherapy might work for your liver cancer. The goal is to find better ways to match you with the right treatment and improve your outcomes.
This study looks at how CT scans of lung cancer can be linked to the tumor's biology and genetics. It aims to understand lung cancer better by combining imaging with lab results.
This study tests whether an AI tool can help doctors read chest CT scans more accurately across the entire lung cancer care process. If you are a doctor who reads chest CT scans, you may be able to join and help improve cancer detection.
This trial uses artificial intelligence to read CT scans and predict how well kidney cancer patients will do after surgery. It aims to help doctors plan better treatment for you.
This study tests an artificial intelligence (AI) system that uses your health information and medical images to better judge cancer risk and support diagnosis and treatment decisions. It may help doctors make more consistent assessments by combining clinical records, imaging, and other lab-style data.
This study looks at using blood and imaging markers to predict if patients with lung cancer who receive both immunotherapy and chest radiation will develop lung inflammation (called radiation lung injury). It may help doctors personalise care and reduce side effects.
Hear when a new Lung Cancer (Diagnosis) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.